Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial.
Cudkowicz M, Genge A, Maragakis N, Petri S, van den Berg L, Aho VV, Sarapohja T, Kuoppamäki M, Garratt C, Al-Chalabi A; REFALS investigators..
.
.
Closing in on complete pathways of biotin biosynthesis.
Lin S, Cronan JE.Lin S, et al..
.
. Cai G, et al.Gastroenterology. 2021 Sep 3:S0016-5085(21)03473-9. doi: 10.1053/j.gastro.2021.08.054. Online ahead of print.Gastroenterology. 2021.PMID: 34487783.
![top](data:image/svg+xml,%3Csvg%20xmlns="http://www.w3.org/2000/svg"%20width="16"%20height="16"%3E%3Crect%20fill-opacity="0"/%3E%3C/svg%3E "top")
